Archive for the ‘Blood / Hematology’ Category
Friday, February 29th, 2008
Baxter International Inc announced yesterday, Thursday 28th February, that it was recalling all remaining multi-dose and single-dose heparin sodium and HEP -LOCK heparin flush products now that alternative suppliers are able to meet national demand for them.
Heparin sodium is a vital ingredient in surgical and medical procedures that has been ...
Posted in Blood / Hematology | No Comments »
Tuesday, February 26th, 2008
Blood clots can save lives, staunching blood loss after injury, but they can also kill. Let loose in the bloodstream, a clot can cause a heart attack, stroke or pulmonary embolism.
A new study reveals in atomic detail how a blood protein that is a fundamental building block of blood clots ...
Posted in Blood / Hematology | No Comments »
Monday, February 25th, 2008
Artisan Pharma, Inc. announced that the Japanese Pharmaceutical and Medical Device Agency approved Artisan's lead drug, ART-123 (human, soluble, recombinant thrombomodulin), on January 25, 2008 for the treatment of disseminated intravascular coagulation ("DIC") in Japan.
The approval of ART-123, which was received by Artisan's partner and licensor of ART-123, Asahi Kasei ...
Posted in Blood / Hematology | No Comments »
Friday, February 22nd, 2008
The U.S. Food and Drug Administration licensed a treatment for hemophilia A, a rare, hereditary blood-clotting disorder that affects approximately 15,000 individuals, almost exclusively males, in the United States.
The new treatment, called Xyntha Antihemophilic Factor (Recombinant) Plasma/Albumin Free, is a genetically engineered version of factor VIII, a protein essential for ...
Posted in Blood / Hematology | No Comments »
Friday, February 22nd, 2008
The discovery of a new anticoagulant with promising therapeutic value is reported on the 20th of February issue of the journal PLoS ONE1. Boophilin - as it was named - is particularly interesting due to a capability to block thrombin - probably the most important (and difficult to inhibit) protein ...
Posted in Blood / Hematology | No Comments »
Wednesday, February 20th, 2008
For many patients, the pain and complications associated with sickle cell disease can have a profound impact on their quality of life, ability to work, and long-term health and well-being. Unfortunately, these challenges are often coupled with significant barriers to care. Hydroxyurea is an FDA-approved therapy for adults with certain ...
Posted in Blood / Hematology | No Comments »
Wednesday, February 20th, 2008
Pyng Medical Corp. (TSX VENTURE:PYT) announced the Company has received Special 510(K) regulatory clearance from the US Food and Drug Administration to market its new and improved version of the award-winning FAST1TM Intraosseous (IO) Infusion System throughout the US, effective immediately.
FAST1TM is the most rapid, reliable and safe alternative to ...
Posted in Blood / Hematology | No Comments »
Tuesday, February 12th, 2008
Clavis Pharma (OSE: CLAVIS) announced that an important milestone has been reached in its haematology program with ELACYT(TM). The phase I part of the ongoing clinical phase I/II study within haematological cancers has been successfully completed. The maximal tolerated dose (MTD) has been determined and clinical activity has been reported. ...
Posted in Blood / Hematology | No Comments »
Wednesday, November 7th, 2007
The transport of oxygen in blood is undertaken by hemoglobin, the largest component of red blood cells. This protein collects oxygen in respiratory organs, mainly in the lungs, and releases it in tissues in order to generate the energy necessary for cell survival. Hemoglobin is one of the most refined ...
Posted in Blood / Hematology | No Comments »
